Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Mar'21
Dec'20
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is -4.45% vs 17.29% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is -32.97% vs 51.22% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is -38.43% vs 36.12% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 40.00% vs 25.00% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Par Drugs & Che. With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
54.71
54.32
0.39
0.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
54.71
54.32
0.39
0.72%
Raw Material Cost
21.71
46.57
-24.86
-53.38%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.35
-1.78
2.13
119.66%
Employee Cost
2.77
2.43
0.34
13.99%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
20.25
3.78
16.47
435.71%
Total Expenditure (Excl Depreciation)
45.08
51.01
-5.93
-11.63%
Operating Profit (PBDIT) excl Other Income
9.63
3.31
6.32
190.94%
Other Income
2.32
0.53
1.79
337.74%
Operating Profit (PBDIT)
11.95
3.84
8.11
211.20%
Interest
0.07
0.57
-0.50
-87.72%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
11.88
3.27
8.61
263.30%
Depreciation
1.84
0.99
0.85
85.86%
Profit Before Tax
10.03
2.29
7.74
337.99%
Tax
2.57
0.76
1.81
238.16%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
7.46
1.53
5.93
387.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
7.46
1.53
5.93
387.58%
Equity Capital
12.30
23.95
-11.65
-48.64%
Face Value
10.00
10.00
0.00
Reserves
94.13
71.19
22.94
32.22%
Earnings per share (EPS)
6.07
0.64
5.43
848.44%
Diluted Earnings per share
6.06
0.64
5.42
846.88%
Operating Profit Margin (Excl OI)
17.60%
6.09%
0.00
11.51%
Gross Profit Margin
21.71%
6.02%
0.00
15.69%
PAT Margin
13.64%
2.82%
0.00
10.82%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 54.71 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -4.45% vs 17.29% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 7.46 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -32.97% vs 51.22% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.63 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -38.43% vs 36.12% in Sep 2024
Half Yearly - Interest
Interest 0.07 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 40.00% vs 25.00% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.60%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024






